Results

Total Results: 2,078 records

Showing results for "drugs".

1561. PowerPoint Presentation
      effectivehealthcare.ahrq.gov/sites/default/files/ebc-webinar-slides.pptx
      June 01, 2014 - PowerPoint Presentation Welcome! Reminder: You will need a phone to take part in this discussion. Click “Audio” at the top of this WebEx screen and then click “Teleconference.” Enter the phone number where you’d like to be called in the second box and click “Call Me.” You will be called within two minutes after …

1562. EBC-webinar-slides (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/ebc-webinar-slides.pdf
      June 01, 2014 - EBC-webinar-slides Source:  www.effectivehealthcare.ahrq.gov       1   The Evidence-Based Care Challenge for NPs and PAs Webinar Recorded March 7, 2013 Text Alternatives Slide  1   The  Evidence-­‐Based  Care  (EBC)  Challenge  for  NPs  and  PAs:    Using  Evidence  in…

1563. Bladder-Cancer-Muscle-Invasive Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-muscle-invasive_executive.pdf
      June 01, 2015 - World Health Organization International Clinical Trials Registry Platform) and regulatory documents (Drugs

1564. Disposition of Comment Report for Wireless Motility Capsule Versus Other Diagnostic Technologies for Evaluating Gastroparesis and Constipation (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_disposition-comments.pdf
      May 20, 2013 - Commentator & Affiliation Section Comment Response gastric emptying (by what few prokinetic drugs … Most of the available drugs have anti-emetic effects on the central nervous system rather on gastric … as half times of emptying, and often perform testing before and after prokinetic stimulation with drugs … We do include off-label use of drugs and technologies available in the US.

1565. Breast Reconstruction After Mastectomy | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/breast-reconstruction-mastectomy/protocol
      June 18, 2020 - Breast Reconstruction After Mastectomy Research Protocol June 18, 2020 Download Main Document PDF 582.1 KB Related Files Download Appendix A [PDF · 25.8 KB] I. Background and Objectives for the Systematic Review Breast cancer is the most common new cancer diagnosis among women and the second most …

1566. Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/transparency-omega-3/research-protocol
      September 06, 2016 - Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease Research Protocol September 6, 2016 Download Main Document PDF 423.8 KB Background Information biases, including publication bias, time-lag bias, selective outcome reporting bias, selective analysis bias, and fraud …

1567. Research Protocol: Breast Reconstruction After Mastectomy (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-reconstruction-mastectomy-protocol.pdf
      April 09, 2020 - Research Protocol: Breast Reconstruction After Mastectomy Evidence-based Practice Center Systematic Review Protocol Project Title: Breast Reconstruction After Mastectomy I. Background and Objectives for the Systematic Review Breast cancer is the most common new cancer diagnosis among women and the second …

1568. Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-omega-3_research-protocol.pdf
      September 02, 2016 - Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease Source: www.effectivehealthcare.ahrq.gov Published online: September 2, 2016 Evidence-based Practice Center Methodology Repor t Protocol Project Title: Transparency of Repor ting Requirements Repor t Topic: Omega-3 Fa…

1569. Disposition of Comments for Technical Brief 29 Women Living With HIV-AIDS (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/women-hiv_disposition-comments.pdf
      November 21, 2016 - Disposition of Comments for Technical Brief 29 Women Living With HIV-AIDS Source: https://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/ ?pageaction=displayproduct&productid=2328 Published Online: November 21, 2016 Technical Brief Disposition of Comments Report Research Rev…

1570. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar-2010_research-protocol.pdf
      January 01, 2010 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: June 2, 2011 Evidence-based Practice Center Systematic Review Protocol Project Title: Comparative Effectiveness and Safety of Insulin Delivery and Glucose Monitoring Methods for Diabetes…

1571. Comparative Effectiveness of Venous Thromboembolism (VTE) Prophylaxis in Orthopedic Surgery | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/blood-clots-hip-knee-surgery/research-protocol
      August 06, 2010 - Boehringer Ingelheim GmbH Investigational drug, not yet FDA approved Desirudin (Iprivask®) Canyon Pharmaceuticals … Lepirudin (Refludan®) Bayer Healthcare Pharmaceuticals Anticoagulation in patients with heparin-associated

1572. Systematic-Review-Integration White-Paper (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/systematic-review-integration_white-paper.pdf
      June 01, 2014 - Findings of Updated Systematic Reviews of Comparative Effectiveness6  Canadian Agency for Drugs … Canadian Agency for Drugs and Technologies in Health.

1573. Healthcare Industry Waste and Lifecycle Assessment (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/lifecycle-assessment-technical-brief-protocol.pdf
      August 23, 2023 - antibiotics, hormone, non-steroidal anti-inflammatory, beta blockers, lipid regulators, and anti- depressant drugs … the most prevalent pharmaceuticals found in the environment.12, 16 There have been negative impacts

1574. Healthcare Industry Waste and Lifecycle Assessment (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/lifecycle-assessment-protocol.pdf
      August 23, 2023 - antibiotics, hormone, non-steroidal anti-inflammatory, beta blockers, lipid regulators, and anti- depressant drugs … the most prevalent pharmaceuticals found in the environment.12, 16 There have been negative impacts

1575. Antiplatelet-Treatment Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_executive.pdf
      September 01, 2013 - Our search included terms for the populations, tests, and drugs of interest. … modification by genotype status by repurposing already completed randomized trials, in which the drugs

1576. Vte-Prophyalaxis Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
      May 01, 2013 - clearance of medications.26-30 Therapies of Interest In this review, we describe the evidence for drugs … Subgroup data are not available for our special populations = 713 Case report of known complications of drugs … Ballerup, Denmark: LEO Pharmaceutical Products; 2008. www.accessdata.fda.gov/ drugsatfda_docs/label/

1577. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
      May 01, 2012 - CER #13: Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer Original release date: February 2008 Surveillance Report: May 2012 Key Findings: • The PIVOT trial was identified, making many of the existing key conclusions out of date. • Key questions 1, 2, and 4 were found t…

1578. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
      May 01, 2012 - CER #13: Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer Original release date: February 2008 Surveillance Report: May 2012 Key Findings: • The PIVOT trial was identified, making many of the existing key conclusions out of date. • Key questions 1, 2, and 4 were found t…

1579. Attention Deficit Hyperactivity Disorder: Executive Summary (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/adhd_executive.pdf
      October 01, 2011 - Attention Deficit Hyperactivity Disorder: Executive Summary                                                                                                                                                                                                                                                       …

1580. Methods Research Report - Framework for Determining Research Gaps During Systematic Review: Evaluation (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/research-gaps_research.pdf
      February 01, 2013 - the name of the intervention that is inadequately included in the evidence base (generic names of drugs … the name of the intervention that is inadequately included in the evidence base (generic names of drugs … the name of the intervention that is inadequately included in the evidence base (generic names of drugs